TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MGNX

MacroGenics Inc

Healthcare · Biotechnology

4.10$ +0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

MacroGenics Inc (MGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 257 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MGNX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
174 359 311 374 332 313 379 335 290 298 262 257
165 342 284 322 269 240 313 280 222 251 217 220
158 196 84 212 220 126 181 123 109 101 183 57
158 339 277 305 233 216 273 244 154 230 202 190
2.9 1.2 2.8 14 30 13 23 10 56 10 4.3 13
0.0 0.0 -8.0 0.0 0.0 0.0 4.4 1.5 1.2 0.0 7.9
6.8 15 18 50 57 68 42 38 30
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
53 46 43 75 89 82 83 96 147 146 146 201
27 24 27 50 60 45 51 75 49 56 56 43
1.6 2.0 1.6 0.3 34 3.0 4.0 4.7 4.7 3.8 4.9 5.2
1.7 3.0 4.0 2.5 4.0 4.3 8.0 16 4.9 6.4 5.0 4.8
0.0 0.0 0.0 0.0
121 313 269 299 243 231 296 240 142 153 116 56
-214 -234 -293 -312 -490 -642 -772 -974 -1,094 -1,103 -1,170 -1,244
27 32 35 36 41 48 52 60 61 62 63 63

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?